Duck Medicine and Vaccines Market, by Type (Medicine and Vaccines), by Application (Farm and Government), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 -

Duck Medicine and Vaccines Market, by Type (Medicine and Vaccines), by Application (Farm and Government), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Duck farming plays a vital role in the poultry industry, which is one of the fastest-growing sectors in the world. Duck diseases are a major cause of concern because they can affect finances of small and landless farmers. Ducks are important to rural livelihoods because they provide a steady supply of meat and eggs. One of the most important measures to prevent outbreaks is to maintain the health of the ducks. Viruses have been reported to have more devastating consequences for duck productivity than other diseases that affect ducks. The most prevalent disease in ducks is Escherichia coli due to poor farm hygiene. Ducks are highly vulnerable to mycotoxins, notably aflatoxin, a toxic and carcinogenic metabolite of Aspergillus flavus that primarily affects the liver. This is a persistent issue that isn't always recognized. A toxin binder, which is a substance added to poultry feed in minute quantities to neutralize or immobilize harmful chemicals, mycotoxins or endotoxins should be included in duck diets on a regular basis. Proper vaccination and treatment can help prevent diseases in ducks.
Market Dynamics
The increasing research and development activities by scientists to develop vaccines for the diseases of ducks are expected to drive the market growth during the forecast period. For instance, in September 2021, scientists at the Department of Veterinary Microbiology, Kerala Veterinary and Animal Sciences University (KVASU), Mannuthy, a university aiming to promote sustainable and profitable animal production systems, developed a vaccine for Riemerellosis, a bacterial disease that causes significant mortality in ducks. In ducks, Riemerellosis causes 5-75 percent mortality and more than 50 percent mortality in ducklings under the age of five weeks.
Key features of the study:
This report provides an in-depth analysis of the global duck medicine and vaccines market, and provides market size (US$ million) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global duck medicine and vaccines market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Boehringer Ingelheim International GmbH., Ceva, YEBIO BIOENGINEERING CO., LTD., NAVETCO, Shangqiu Meilan Biological Engineering Co.,Ltd., Merck & Co., Inc., EGAVET, Bioveta, a.s., Jilin Zhengye Biological Products company limited, and Harbin Pharmaceutical Group Bio-vaccine Co. Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global duck medicine and vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global duck medicine and vaccines market
Detailed Segmentation:
Global Duck Medicine and Vaccines Market, By Type:
Medicine
Vaccines
Global Duck Medicine and Vaccines Market, By Application:
Farm
Application
Global Duck Medicine and Vaccines Market, By Region:
North America
By Type
Medicine
Vaccines
By Application
Farm
Government
By Country
U.S.
Canada
Latin America
By Type
Medicine
Vaccines
By Application
Farm
Government
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Type
Medicine
Vaccines
By Application
Farm
Government
By Country
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Type
Medicine
Vaccines
By Application
Farm
Government
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Type
Medicine
Vaccines
By Application
Farm
Government
By Country
GCC
Israel
Rest of Middle East
Africa
By Type
Medicine
Vaccines
By Application
Farm
Government
By Country
South Africa
Central Africa
North Africa
Company Profiles
Boehringer Ingelheim International GmbH
Company Highlights
Products Portfolio
Key Highlights
Financial Performance
Strategies
Ceva
YEBIO BIOENGINEERING CO., LTD.
NAVETCO
Shangqiu Meilan Biological Engineering Co.,Ltd.
Merck & Co., Inc.
EGAVET
Bioveta, a.s.
Jilin Zhengye Biological Products company limited
Harbin Pharmaceutical Group Bio-vaccine Co. Ltd.
“*” marked represents similar segmentation in other categories in the respective section.